![]() 988,684,481 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
neostigmine |
Also found in: Dictionary/thesaurus, Medical, Wikipedia | 0.04 sec. |
|
neostigmine (nē'ōstĭg`mēn, –mĭn), drug used to mimic the effects of stimulation of the parasympathetic nervous system nervous system, network of specialized tissue that controls actions and reactions of the body and its adjustment to the environment. Virtually all members of the animal kingdom have at least a rudimentary nervous system. ..... Click the link for more information. . Along with several other drugs that have a similar mode of action, it inhibits the action of the enzyme cholinesterase, which destroys the substance acetylcholine acetylcholine (əsēt'əlkō`lēn), a small organic molecule liberated at nerve endings as a neurotransmitter . ..... Click the link for more information. at nerve endings. Because neostigmine increases the effective concentration of acetylcholine, it causes such body changes as contraction of the pupils, increased activity of intestinal muscles, and increased secretion by the salivary and sweat glands. It will cause menstrual bleeding in a nonpregnant woman whose menstrual period is delayed, and it is therefore used as a pregnancy test. Neostigmine and related drugs are also used to diagnose and control the neuromuscular disease myasthenia gravis. Because neostigmine causes decreased fluid pressure in the eye it is used to treat certain types of glaucoma. The drug atropine atropine (ăt`rəpēn, –pĭn) ..... Click the link for more information. is sometimes given along with neostigmine to prevent the latter's side effects. Ephedrine ephedrine (ĭfĕd`rĭn, ĕf`ĭdrēn'), drug derived from plants of the genus Ephedra ..... Click the link for more information. often enhances the action of neostigmine. |
|
? Mentioned in | ? References in periodicals archive | |
|---|---|---|
The panel removed midazolam and baclofen from line-four and neostigmine, adenosine and ketorolac from line-five due to lack of adequate clinical evidence to support their general use for chronic pain. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|